4Filing Date: May 6, 2026

Tempus AI

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0002113721-26-000004
Total Value$0
Trades1
Insiders1

Transaction Details

Schoenherr Thomas Edward
CEO, Diagnostics·Direct
Grant · Acquire
Class A Common Stock
Shares+13.64K
Price$0.00
Total Value$0
Shares Owned After108.61K
Transaction DateMay 4, 2026
Footnotes ▸

Represents two restricted stock unit ("RSU") grants, consisting of (i) 3,642 RSUs that are fully vested, and (ii) 10,000 RSUs, which vest in eight equal quarterly installments commencing on November 15, 2026.

Post-Transaction Holdings

Schoenherr Thomas Edward · CEO, Diagnostics
SecuritySharesChange
Class A Common Stock108.61K+13.64K (14.36%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-04 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Tempus AI, Inc. (TEM) CIK: 0001717115 --- Reporting Owner --- Name: Schoenherr Thomas Edward CIK: 0002113721 Role: Officer (CEO, Diagnostics) --- Non-Derivative Transactions --- [Transaction #1] Security: Class A Common Stock Date: 2026-05-04 | Code: A (Grant or award) Shares: +13,642 | Price: $0.00 Shares Owned After: 108,609 | Ownership: D (Direct) Footnotes: [F1] Represents two restricted stock unit ("RSU") grants, consisting of (i) 3,642 RSUs that are fully vested, and (ii) 10,000 RSUs, which vest in eight equal quarterly installments commencing on November 15, 2026. --- Footnotes (Complete Index) --- F1: Represents two restricted stock unit ("RSU") grants, consisting of (i) 3,642 RSUs that are fully vested, and (ii) 10,000 RSUs, which vest in eight equal quarterly installments commencing on November 15, 2026. --- Signature --- /s/ /s/ Andrew Polovin, Attorney-in-Fact (2026-05-06)

keid analysis is for reference only and does not constitute investment advice.